2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Saturday, October 6, 2018

1:45pm-3:15pm: Poor responders to STN DBS in Parkinson’s disease: 1 year follow-up study

M. Zibetti, L. Ricciardi, E. Montanaro, M. Sarchioto, M. Edwards, L. Lopiano, F. Morgante (Toriino, Italy)

Surgical Therapy: Parkinson's Disease · Hall 3FG

1:45pm-3:15pm: Post-Deep Brain Stimulation Psychosis in Parkinson’s Disease: A Meta-analysis

YC. Tai, N. Mahant, B. Stubbs, A. Carvalho, YW. Chen, TY. Chen, SP. Hsu, PT. Tseng (Kaohsiung, Taiwan)

Surgical Therapy: Parkinson's Disease · Hall 3FG

1:45pm-3:15pm: PPMI driven sample size estimation for clinical trials in Parkinson’s disease

K. Marek, J. Seibyl, C. Caspell-Garcia, C. Coffey, B. Mollenhauer, K. Kieburtz, C. Tanner, L. Chahine, A. Siderowf, T. Simuni (New Haven, CT, USA)

Clinical Trials and Therapy in Movement Disorders · Hall 3FG

1:45pm-3:15pm: Practice patterns, motor outcomes and health disparities in patients undergoing Deep Brain Stimulation for Parkinson’s disease

C. Luca, D. Garbin diLuca, H. Moore, C. Singer, I. Cajigas, J. Jagid (Miami, FL, USA)

Surgical Therapy: Parkinson's Disease · Hall 3FG

1:45pm-3:15pm: Preclinical evaluation of a novel autologous substrate for cell-based therapy

S. Benoit, H. Xu, J. Ronald, P. Foster, S. Schmid, M. Hebb (London, ON, Canada)

Therapy in Movement Disorders: Gene and Cell-Based Therapies · Hall 3FG

1:45pm-3:15pm: Predicting patient risk and discharge disposition subsequent to deep brain stimulation surgery

F. Farrokhi (Seattle, WA, USA)

Surgical Therapy: Parkinson's Disease · Hall 3FG

1:45pm-3:15pm: Predictor for speech deterioration following STN-DBS in PD patients

Y. Tanaka, T. Tsuboi, H. Watanabe, D. Nakatsubo, S. Maesawa, S. Kato, Y. Kajita, M. Sato, R. Odake, M. Hattori, M. Yamamoto, T. Wakabayashi, M. Katsuno, G. Sobue (Nagoya, Japan)

Surgical Therapy: Parkinson's Disease · Hall 3FG

1:45pm-3:15pm: Preliminary evidence for an altered relationship between uric acid levels and resting state functional connectivity in REM sleep behavior disorder

M. Schiess, J. Suescun, L. Giancardo, R. Castriotta, T. Ellmore (Houston, TX, USA)

Neuroimaging (Non-PD) · Hall 3FG

1:45pm-3:15pm: Prevalence, Distribution and Management of Parkinson among Pakistani Population

S. Naureen (Rawalpindi, Pakistan)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Primary familial brain calcification – The impact of calcifications on the development of motor symptoms

D. Alvarez-Fischer, C. Schiemenz, G. Mahlke, A. Keller, A. Westenberger, J. Erdmann, Z. Aherrahrou, C. Klein (Lübeck, Germany)

Pathophysiology (Other Movement Disorders) · Hall 3FG